DOW
NYSE · Chemicals
Dow Inc
$31.40
-0.58 (-1.81%)
Financial Highlights (FY 2026)
Revenue
40.96B
Net Income
-2,687,846,245
Gross Margin
6.5%
Profit Margin
-6.6%
Rev Growth
-11.1%
D/E Ratio
1.13
Revenue & Net Income
Margin Trends
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Gross Margin | 6.5% | 6.5% | 35.8% | 35.8% |
| Operating Margin | -4.7% | -4.2% | 12.5% | 11.1% |
| Profit Margin | -6.6% | -6.2% | 9.5% | 10.8% |
Income Statement
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Revenue | 40.96B | 46.07B | 12.07B | 13.10B |
| Gross Profit | 2.65B | 2.98B | 4.31B | 4.68B |
| Operating Income | -1,920,820,314 | -1,944,806,257 | 1.51B | 1.46B |
| Net Income | -2,687,846,245 | -2,721,410,305 | 1.15B | 1.41B |
| Gross Margin | 6.5% | 6.5% | 35.8% | 35.8% |
| Operating Margin | -4.7% | -4.2% | 12.5% | 11.1% |
| Profit Margin | -6.6% | -6.2% | 9.5% | 10.8% |
| Rev Growth | -11.1% | -11.1% | +20.5% | -2.1% |
Balance Sheet
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| Total Debt | 6.08B | 6.08B | 3.27B | 3.76B |
| Total Equity | 5.36B | 5.36B | 16.36B | 14.86B |
| D/E Ratio | 1.13 | 1.13 | 0.20 | 0.25 |
Cash Flow
| FY 2026 | FY 2025 | FY 2024 | FY 2023 | |
|---|---|---|---|---|
| EBITDA | -1,682,592,770 | -1,798,248,544 | 1.76B | 1.70B |
| Free Cash Flow | — | — | 1.48B | 1.41B |